Literature DB >> 10971171

Loss of heterozygosity on the short arm of chromosome 3 in renal cancer.

M L Maestro1, V del Barco, M T Sanz-Casla, J Moreno, E Adrover, L Izquierdo, I Zanna, C Fernández, E Redondo, J Blanco, L Resel.   

Abstract

3% of human cancers are renal cell carcinomas (RCC). The most common chromosome abnormality found in this tumor is loss of heterozygosity (LOH) on the short arm of chromosome 3, which suggests that there must be one or more tumor suppressor genes between 3p14 and 3p21 near the VHL gene which play a relevant role in renal cancer development. DNA from normal and tumor tissue from 40 patients at various stages of RCC was analyzed for LOH at three microsatellites mapped to 3p (3p14.1-14.3; 3p21.2-21.3 and 3p25) by polymerase chain reaction). 42.5% of the tumors studied showed LOH on at least one locus. 30% showed LOH on only one locus; 5% on two loci and 7.5% on the three loci tested. LOH occurred only on nonpapillary tumors (p = 0.03). Interestingly, all the tumors with LOH on 3p21 were >/=25 mm (p = 0.04; relative risk 1.76, confidence interval: 1.3-2.3). Copyright 2000 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2000        PMID: 10971171     DOI: 10.1159/000012149

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  7 in total

1.  The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis.

Authors:  K Dreijerink; E Braga; I Kuzmin; L Geil; F M Duh; D Angeloni; B Zbar; M I Lerman; E J Stanbridge; J D Minna; A Protopopov; J Li; V Kashuba; G Klein; E R Zabarovsky
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-05       Impact factor: 11.205

2.  Molecular cloning and characterization of CIDE-3, a novel member of the cell-death-inducing DNA-fragmentation-factor (DFF45)-like effector family.

Authors:  Liang Liang; Mujun Zhao; Zhenhua Xu; Kazunari K Yokoyama; Tsaiping Li
Journal:  Biochem J       Date:  2003-02-15       Impact factor: 3.857

3.  Genome-wide profiling of chromosomal alterations in renal cell carcinoma using high-density single nucleotide polymorphism arrays.

Authors:  Meng Chen; Yuanqing Ye; Hushan Yang; Pheroze Tamboli; Surena Matin; Nizar M Tannir; Christopher G Wood; Jian Gu; Xifeng Wu
Journal:  Int J Cancer       Date:  2009-11-15       Impact factor: 7.396

4.  Investigation of recurrent deletion loci specific to conventional renal cell carcinoma by comparative allelotyping in major epithelial carcinomas.

Authors:  Rashmi R Bhat Singh; Pratibha S Amare Kadam
Journal:  Indian J Urol       Date:  2012-01

5.  ADIPOQ polymorphism rs182052 is associated with clear cell renal cell carcinoma.

Authors:  Guiming Zhang; Chengyuan Gu; Yao Zhu; Lei Luo; Dahai Dong; Fangning Wan; Hailiang Zhang; Guohai Shi; Lijiang Sun; Dingwei Ye
Journal:  Cancer Sci       Date:  2015-04-24       Impact factor: 6.716

6.  Impact of an altered Wnt1/β-catenin expression on clinicopathology and prognosis in clear cell renal cell carcinoma.

Authors:  Stephan Kruck; Christian Eyrich; Marcus Scharpf; Karl-Dietrich Sievert; Falco Fend; Arnulf Stenzl; Jens Bedke
Journal:  Int J Mol Sci       Date:  2013-05-24       Impact factor: 5.923

7.  Impact of Estrogen on the Relationship Between Obesity and Renal Cell Carcinoma Risk in Women.

Authors:  Lijiang Sun; Fan Chao; Bo Luo; Dingwei Ye; Jun Zhao; Qiang Zhang; Xiaocheng Ma; Guiming Zhang
Journal:  EBioMedicine       Date:  2018-07-17       Impact factor: 8.143

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.